Janet Forgenie provides an overview of how COVID-19 has impacted prostate cancer care and side effect management at a large university hospital in central London, UK.
Please submit your clinical topic for the next GU Nurses CONNECT newsletter here.
Setting up for treatment success: Podcast on management of patients receiving VEGFR-TKI treatment for select solid tumours
In this podcast, Veerle Lamotte and Paola Belardi discuss the use of VEGFR-TKIs in the treatment of patients with hepatocellular cancer (HCC), differentiated thyroid cancer (DTC) and advanced renal cell carcinoma (aRCC).
GU Nurses CONNECT expert, Joanne Chien, MSN, RN, GNP-BC provides an overview of practical considerations when sequencing treatments for mCRPC patients in clinical practice.
Overview of safety considerations for next-generation androgen receptor inhibitors for nmCRPC: The role of the nurse
Jennifer Sutton, RN, BS, CCRC provides an overview of safety considerations for next-generation androgen receptor inhibitors for non- metastatic castration resistant prostate cancer and the role of the nurse.
Brenda Martone MSN, ANP-BC, AOCNP summarises how a GU nurse can provide crucial support to patients during treatment sequencing decisions for metastatic castration-resistant prostate cancer (mCRPC).
There are currently no GU Nurses CONNECT courses. See other COR2ED courses at: COR2ED Checkpoint.